Evidence method
Level · gp.fundamentals.capex_revenue_ratio
14.06% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
DXCM · Sep 30, 2022
DEXCOM INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001093557-22-000171General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
38.10% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
18.36% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
40.41% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
64.22% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
19.17% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
14.33% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
4.00% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History21 statesSelf-history eligible
Mar 31, 20190/7 normalizedLevel 3Jun 30, 20190/7 normalizedLevel 3Sep 30, 20190/7 normalizedLevel 3Dec 31, 20190/8 normalizedLevel 3Mar 31, 20200/8 normalizedLevel 3Jun 30, 20200/8 normalizedLevel 3Sep 30, 20200/8 normalizedLevel 3Dec 31, 20207/8 normalizedLevel 3Mar 31, 20217/8 normalizedLevel 3Jun 30, 20217/8 normalizedLevel 3Sep 30, 20217/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Sep 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 13.14%
- Current
- 14.06%
- Delta
- 0.92%
- Previous
- 24.82%
- Current
- 38.10%
- Delta
- 13.28%
- Previous
- 16.99%
- Current
- 18.36%
- Delta
- 1.37%
- Previous
- 48.76%
- Current
- 40.41%
- Delta
- -8.35%
- Previous
- 64.56%
- Current
- 64.22%
- Delta
- -0.35%
- Previous
- 11.06%
- Current
- 19.17%
- Delta
- 8.11%
- Previous
- 17.48%
- Current
- 14.33%
- Delta
- -3.15%
- Previous
- 4.68%
- Current
- 4.00%
- Delta
- -0.68%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · DXCM Fundamental State →Has State · DEXCOM INC →Transitioned To · DXCM Fundamental State →Transitioned To · DXCM MARGIN_DECREASED →Transitioned To · DXCM PROFITABILITY_INCREASED →Transitioned To · DXCM R_AND_D_INTENSITY_DECREASED →Transitioned To · DXCM SBC_INTENSITY_DECREASED →Transitioned To · DXCM CAPEX_INTENSITY_INCREASED →Transitioned To · DXCM CASH_GENERATION_INCREASED →Transitioned To · DXCM GROWTH_INCREASED →Transitioned To · DXCM INVENTORY_PRESSURE_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.